(Q33999920)

30 July 2017

1 reference

title

Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies (English)

1 reference

30 July 2017

main subject

chronic heart failure

1 reference

Swedberg K

1

1 reference

30 July 2017

publication date

1 September 2000

1 reference

European Journal of Heart Failure

30 July 2017

published in

1 reference

30 July 2017

volume

2

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

229-233

1 reference

Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

A decade of angiotensin-converting enzyme (ACE) inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

beta Blockade after myocardial infarction: systematic review and meta regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

The LIDO, HOPE, MOXCON and WASH studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure. Moxonidine Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900102-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S1388-9842(00)00102-1

1 reference

30 July 2017

1 reference